Malignant : How Bad Policy and Bad Evidence Harm People with Cancer

Malignant : How Bad Policy and Bad Evidence Harm People with Cancer


How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective.

Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel-but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Throughout this work, Prasad illuminates deceptive practices which

* promote novel cancer therapies long before credible data are available to support such treatment; and
* exaggerate the potential benefits of new therapies, many of which cost thousands and in some cases hundreds of thousands of dollars.

Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration.

This is a book about how the actions of human beings-our policies, our standards of evidence, and our drug regulation-incentivize the pursuit of marginal or unproven therapies at lofty and unsustainable prices. Prasad takes us through how cancer trials are conducted, how drugs come to market, and how pricing decisions are made, asking how we can ensure that more cancer drugs deliver both greater benefit and a lower price. Ultimately, Prasad says,

* more cancer clinical trials should measure outcomes that actually matter to people with cancer;
* patients on those trials should look more like actual global citizens;
* we need drug regulators to raise, not perpetually lower, the bar for approval; and
* we need unbiased patient advocates and experts.

This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer-and how we can avoid repeating the policy and practice mistakes of the past.

Similar Books

ISBN 10: 1421429047
ISBN 13: 9781421429045

14 May 2019
Vinayak K. Prasad

ISBN 10: 1439170916
ISBN 13: 9781439170915

01 Oct 2011
Siddhartha Mukherjee

ISBN 10: 1541699521
ISBN 13: 9781541699526

04 Jun 2020
Azra Raza

ISBN 10: 1541644638
ISBN 13: 9781541644632

11 Jul 2019
Eric Topol

ISBN 10: 0190922885
ISBN 13: 9780190922887

23 Jul 2020
Robin Dunbar

ISBN 10: 1541797736
ISBN 13: 9781541797734

16 Jun 2020
Ezekiel J Emanuel

ISBN 10: 1786497166
ISBN 13: 9781786497161

15 Nov 2020
Johan Norberg

ISBN 10: 0190675659
ISBN 13: 9780190675653

11 May 2017
David S. Moore

ISBN 10: 1541699513
ISBN 13: 9781541699519

10 Dec 2020
Azra Raza

ISBN 10: 0262525844
ISBN 13: 9780262525848

09 May 2014
Eva Jablonka

ISBN 10: 0233005927
ISBN 13: 9780233005928

04 Feb 2020
Dr Kat Arney

ISBN 10: 0008296707
ISBN 13: 9780008296704

19 Mar 2020
Frank Ryan